InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,995.54
(
0.38%
)
US TECH 100
20,562.80
(
0.10%
)
Dow Jones
43,988.99
(
0.59%
)
Brent Oil
73.90
(
-2.07%
)
Bitcoin
76,555.96
(
0.86%
)
Post# of 3283
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dcaf7

Send PM Follow Ignore
Followers 3
Posts 300
Boards Moderated 0
Alias Born 12/21/2022

dcaf7

Re: ATLcitizen post# 3230

Thursday, 04/06/2023 1:31:41 PM

Thursday, April 06, 2023 1:31:41 PM

Post# of 3283
Yes, Poziotinib works. But toxicity issues are real. For any company who is thinking buy it, you need to consider a necessary phase 3 trial and competition. I can see a few drugs in clinical trials that can potentially work as Pozi but less toxic. Will be interesting to see Pyrotinib data.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

SANUWAVE Announces Record Quarterly Revenues:  Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM

DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM

SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM

Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM

SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM

VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM

Start posting your company's news
Only $200 per official company press release!